HSP90B2P and interstitial lung disease: Furthermore, in this constant quest for predictive biomarkers, a deeper investigation of the relevance of anti-HSP autoantibodies in RA-ILD may be interesting in order to anticipate and mitigate their pulmonary manifestations (Figure 2, Table 2).